Pattali Shinoj, Hu Shimin, Bashir Qaiser, Champlin Richard E, Qazilbash Muzaffar H
Department of Hematology/Oncology, Ashtabula Regional Medical Center/Cleveland Clinic, Cleveland, USA.
Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, USA.
Cureus. 2024 Nov 13;16(11):e73583. doi: 10.7759/cureus.73583. eCollection 2024 Nov.
The synchronous presentation of chronic myeloid leukemia (CML) and multiple myeloma (MM) is extremely rare. CML is a myeloproliferative neoplasm originating from an abnormal pluripotent hematopoietic stem cell. It is associated with the - fusion gene located on the Philadelphia chromosome. In contrast, multiple myeloma is a multifocal, bone marrow-based plasma cell neoplasm associated with the production of M-protein in the serum and/or urine. We present a case with a synchronous diagnosis of chronic myeloid leukemia and multiple myeloma. Both cancers were aggressively treated. The patient received autologous stem cell transplantation (ASCT) for multiple myeloma and tyrosine kinase inhibitor for chronic myeloid leukemia concurrently to achieve the complete response.
慢性髓性白血病(CML)与多发性骨髓瘤(MM)同时出现极为罕见。CML是一种起源于异常多能造血干细胞的髓系增殖性肿瘤。它与位于费城染色体上的 - 融合基因相关。相比之下,多发性骨髓瘤是一种多灶性、以骨髓为基础的浆细胞肿瘤,与血清和/或尿液中M蛋白的产生有关。我们报告一例同时诊断为慢性髓性白血病和多发性骨髓瘤的病例。两种癌症均接受了积极治疗。患者同时接受了针对多发性骨髓瘤的自体干细胞移植(ASCT)和针对慢性髓性白血病的酪氨酸激酶抑制剂治疗,以实现完全缓解。